During the past decade, Taizhou Central Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Taizhou Central Hospital" #1 sponsor was "Zhejiang Cancer Hospital" with 2 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored, "Shanghai Jiao Tong University School of Medicine" with 1 trials sponsored, "Shenyang Northern Hospital" with 1 trials sponsored and "Taizhou Hospital" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Taizhou Central Hospital" #1 collaborator was "Taizhou Cancer Hospital" with 1 trials as a collaborator and "Taizhou Enze Medical Center (Group) Enze Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Taizhou Central Hospital" are "Breast Neoplasm" (1 trials), "Camrelizumab" (1 trials), "Cervical Cancer" (1 trials), "Nasopharyngeal Carcinoma" (1 trials) and "Oncolytic Virotherapy" (1 trials). Many other conditions were trialed in "Taizhou Central Hospital" in a lesser frequency.

Most popular intervention types in "Taizhou Central Hospital" are "Drug" (5 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Anlotinib" (1 trials), "Anlotinib(blank)" (1 trials), "Bivalirudin" (1 trials), "Chemotherapy" (1 trials) and "Conventional dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Taizhou Central Hospital" are 3 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Taizhou Central Hospital". 1 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Taizhou Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Taizhou Central Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".